Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | 0.00% | 0.00% | +14.29% |
May. 16 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.43M | |
+54.10% | 55.7B | |
+41.08% | 39.91B | |
-5.63% | 39.57B | |
-5.56% | 28.16B | |
+16.33% | 26.3B | |
-20.41% | 18.94B | |
+32.98% | 12.17B | |
+26.77% | 12.12B | |
+2.20% | 12.12B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial